Znanstveni rad - Pregledni rad
Advances in Risk Stratification and Treatment of Polycythemia Vera and Essential Thrombocythemia
Current Hematologic Malignancy Reports, 17 (2022), 5; 155-169. https://doi.org/10.1007/s11899-022-00670-8

Krečak, Ivan; Lucijanić, Marko; Verstovšek, Srđan

Citirajte ovaj rad

Krečak, I., Lucijanić, M. i Verstovšek, S. (2022). Advances in Risk Stratification and Treatment of Polycythemia Vera and Essential Thrombocythemia. Current Hematologic Malignancy Reports, 17. (5), 155-169. doi: 10.1007/s11899-022-00670-8

Krečak, Ivan, et al. "Advances in Risk Stratification and Treatment of Polycythemia Vera and Essential Thrombocythemia." Current Hematologic Malignancy Reports, vol. 17, br. 5, 2022, str. 155-169. https://doi.org/10.1007/s11899-022-00670-8

Krečak, Ivan, Marko Lucijanić i Srđan Verstovšek. "Advances in Risk Stratification and Treatment of Polycythemia Vera and Essential Thrombocythemia." Current Hematologic Malignancy Reports 17, br. 5 (2022): 155-169. https://doi.org/10.1007/s11899-022-00670-8

Krečak, I., Lucijanić, M. i Verstovšek, S. (2022) 'Advances in Risk Stratification and Treatment of Polycythemia Vera and Essential Thrombocythemia', Current Hematologic Malignancy Reports, 17(5), str. 155-169. doi: 10.1007/s11899-022-00670-8

Krečak I, Lucijanić M, Verstovšek S. Advances in Risk Stratification and Treatment of Polycythemia Vera and Essential Thrombocythemia. Current Hematologic Malignancy Reports [Internet]. 06.08.2022. [pristupljeno 11.07.2024.];17(5):155-169. doi: 10.1007/s11899-022-00670-8

I. Krečak, M. Lucijanić i S. Verstovšek, "Advances in Risk Stratification and Treatment of Polycythemia Vera and Essential Thrombocythemia", Current Hematologic Malignancy Reports, vol. 17, br. 5, str. 155-169, Kolovoz 2022. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:950177. [Citirano: 11.07.2024.]

Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.